SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $364 | +5.8% | 3 | 0.0% | 0.00% | – |
| Q2 2023 | $344 | -99.0% | 3 | -98.8% | 0.00% | -100.0% |
| Q1 2023 | $35,147 | +7.2% | 255 | +0.8% | 0.00% | 0.0% |
| Q4 2022 | $32,784 | +17.1% | 253 | +1.2% | 0.00% | 0.0% |
| Q3 2022 | $28,000 | +47.4% | 250 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $19,000 | -5.0% | 250 | -83.2% | 0.00% | -77.8% |
| Q1 2015 | $20,000 | -9.1% | 1,490 | 0.0% | 0.01% | +200.0% |
| Q4 2014 | $22,000 | -26.7% | 1,490 | +4.2% | 0.00% | -40.0% |
| Q3 2014 | $30,000 | -30.2% | 1,430 | 0.0% | 0.01% | -37.5% |
| Q2 2014 | $43,000 | – | 1,430 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |